Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice setting.

@article{Dowson2008ClinicalPO,
  title={Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice setting.},
  author={Andrew J. Dowson and Shaun G. Kilminster and Rebecca Salt},
  journal={Drugs in R&D},
  year={2008},
  volume={9 3},
  pages={147-58}
}
BACKGROUND AND OBJECTIVES Some evidence for the efficacy of botulinum toxin A as a preventive treatment for chronic primary headaches has been reported in randomized, controlled clinical studies. This study investigated the clinical profile of botulinum toxin A in a naturalistic clinical practice setting in a population of patients with cervical dystonia associated with chronic headache and a history of migraine. METHODS This was a prospective, open-label, longitudinal study. Following a… CONTINUE READING